It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of 2011. During the year BPL achieving a 21.6% increase in sales to Taka. 7,890.24 million (2010: Tk. 6,490.85 million). Sales of the company’s Active Pharmaceutical Ingredients (APIs) also recorded a significant 37.1% growth to reach Taka. 486.91 million (2010: Tk. 355.24 million). In 2011 export sales grew by 18.1% to Taka. 390.32 million (2010: Tk. 330.54 million). Along with sales growth, Beximco Pharma also achieved a marked growth in profit in 2011. The Company’s pre-tax profit increased 23.2% to Taka. 1,677.85 million (2010: Tk. 1,361.53 million).
The Board of Directors has recommended 21% stock dividend for approval of the shareholders for the year ended 31st December 2011. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Beximco Pharmaceuticals Limited :
- Annual Report 2001 of Beximco Pharmaceuticals Limited
- Annual Report 2002 of Beximco Pharmaceuticals Limited
- Annual Report 2003 of Beximco Pharmaceuticals Limited
- Annual Report 2004 of Beximco Pharmaceuticals Limited
- Annual Report 2005 of Beximco Pharmaceuticals Limited
- Annual Report 2006 of Beximco Pharmaceuticals Limited
- Annual Report 2007 of Beximco Pharmaceuticals Limited
- Annual Report 2008 of Beximco Pharmaceuticals Limited
- Annual Report 2009 of Beximco Pharmaceuticals Limited
- Annual Report 2010 of Beximco Pharmaceuticals Limited
- Annual Report 2011 of Beximco Pharmaceuticals Limited
- Annual Report 2012 of Beximco Pharmaceuticals Limited
- Annual Report 2013 of Beximco Pharmaceuticals Limited
- Annual Report 2014 of Beximco Pharmaceuticals Limited
- Auditors’ Report 2015 of Beximco Pharmaceuticals Limited
- Annual Report 2016 of Beximco Pharmaceuticals Limited
- Auditors’ Report 2017 of Beximco Pharmaceuticals Limited
